๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Targeted therapy for small cell lung cancer

โœ Scribed by Apar Kishor Ganti; Amit W. Panwalkar

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
205 KB
Volume
2
Category
Article
ISSN
1776-2596

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adjuvant therapy of non-small cell lung
Adjuvant therapy of non-small cell lung cancer
โœ E. Carmack Holmes ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 251 KB ๐Ÿ‘ 2 views

One hundred and forty thousand patients in the United States will develop lung cancer annually. About one half of these will have disease confined to the thorax with no clinical evidence of dissemination (Figure 1). A relatively high proportion of these patients will actually have disease that can b

Recent advances in etoposide therapy for
Recent advances in etoposide therapy for non-small cell lung cancer
โœ Philip Bonomi ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of

Small-cell lung cancer: An overview of i
Small-cell lung cancer: An overview of issues in therapy
โœ Robert E. Wittes ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 917 KB

As one of the few chemo-and radiosensitive neoplasms among the common epithelial solid tumors of adults, small-cell lung cancer has long tantalized clinical investigators. Although for the last 15-20 years therapy has yielded high remission rates, including substantial complete remission rates, resu